Drug Safety Matters

51 Folgen

1. #34 Veterinary pharmacovigilance, Part I – James Mount

   Vom: 17.12.2024
2. #33 Narrative fields and signal assessors, an exploratory study – Joana Félix and Alem Zekarias

   Vom: 29.11.2024
3. #32 Pharmacovigilance in older adults – Giovanni Furlan

   Vom: 25.10.2024
4. #31 A guide to reporting disproportionality analyses – Michele Fusaroli and Daniele Sartori

   Vom: 30.9.2024
5. Uppsala Reports Long Reads – Weeding out duplicates to better detect side effects

   Vom: 26.8.2024
6. Uppsala Reports Long Reads – Ensuring trust in AI/ML when used in pharmacovigilance

   Vom: 27.6.2024
7. #30 Preventing and reporting medication errors – Rabat CC & UMC

   Vom: 15.5.2024
8. #29 When medicines change our behaviour – Michele Fusaroli

   Vom: 23.4.2024
9. #28 Catching black swans – François Montastruc

   Vom: 29.2.2024
10. #27 When drugs damage the liver – Rita Baião

    Vom: 1.2.2024
11. #26 What's trending in pharmacovigilance? – Angela Caro

    Vom: 20.12.2023
12. #25 A week in the name of medicines safety – part 2

    Vom: 13.11.2023
13. #24 A week in the name of medicines safety – part 1

    Vom: 2.11.2023
14. Uppsala Reports Long Reads – The colour of signals

    Vom: 29.9.2023
15. Uppsala Reports Long Reads – Empowering patients as partners

    Vom: 5.9.2023
16. #23 Assessing safety in clinical trials – Marianne Lunzer & Sanja Prpić

    Vom: 27.6.2023
17. #22 Reforming pharmacovigilance education – Michael Reumerman

    Vom: 8.5.2023
18. #21 Unlocking the power of real-world data – Patrick Ryan

    Vom: 30.3.2023
19. #20 The evidence for signals – Daniele Sartori

    Vom: 23.2.2023
20. Uppsala Reports Long Reads – Unmasking data in the COVID-19 vaccine era

    Vom: 26.1.2023